Breaking News Headlines Today

News from 340breport.com

See all of 340breport.com news coverage in one place. Discover how 340breport.com’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 138 have been published by 340breport.com which Ground News has aggregated in the past 3 months.

The Ground News media bias check for 340breport.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if 340breport.com is credible or reliable, look no further. We rank 340breport.com as Unknown factuality. Find out more about our methodology here.

Information about 340breport.com

Where is 340breport.com located?340breport.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top 340breport.com News

Oregon, United States · Oregon

Novartis sues Oregon over new law on discounted drug access

100% Center coverage: 1 sources

Pharmaceutical company Novartis is suing the Oregon Board of Pharmacy to stop a new state law that would expand how safety-net providers can get discounted prescription drugs.See the Story

United States · United States

In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance - 340B Report

A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four major drugmakers had illegally colluded to deny 340B pricing on insulin and other diabetes medicines through contract pharmacy restrictions, can continue in district court—a ruling which the health centers’ attorney described as “a watershed moment for safety-net providers.”Read Article

United States · United States

HHS Touts 340B Rebate Pilot Proposal to Appeals Court, Hospitals File Amicus Brief Urging Court to Reject Rebates - 340B Report

The U.S. Department of Health and Human Services (HHS) touted the agency’s recently announced plan to pilot a 340B rebate model, offering in a new federal appeals court filing that the “methodical and thoughtful approach” will “ensure a fair and transparent 340B rebate model process for all stakeholders involved.”Read Article

Judge Rejects HHS’ Partial Motion to Dismiss in Drugmakers’ Lawsuit Challenging STD Site Recertifications - 340B Report

A Washington D.C. federal court this week rejected the Department of Health and Human Services’ (HHS) request to partially dismiss three drugmakers’ arguments in a lawsuit alleging that the federal government allowed certain STD clinics to unlawfully participate in the 340B program.Washington DC · Washington Read Article

Trump Calls on Drugmakers to Implement ‘Most Favored Nation’ Pricing, Resurrects Idea to Extend MFN to all Medicaid Patients - 340B Report

President Donald Trump is urging more than a dozen leading pharmaceutical manufacturers to begin implementing his proposed “most-favored nation” (MFN) model for prescription drugs, which aims to bring the prices the U.S. pays for medications in line with those paid by other developed countries, including for all Medicaid patients.United States · United States Read Article

Senate HELP Committee Chairman Again Criticizes 340B Hospitals and Calls for Reforms at Hearing - 340B Report

A key Senate Republican and outspoken 340B critic recently argued that any comprehensive efforts to address healthcare affordability in Congress must include reforms to the drug pricing program, including those he proposed following his yearslong investigation into how certain hospitals, health centers, chain pharmacies and drugmakers operate their 340B programs.United States · United States Read Article

Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States - 340B Report

A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...] The post Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States appeared first on 340B Report.North Carolina · North Carolina Read Article

State Contract Pharmacy Lawsuit Roundup: Hearing in Utah; Updates in Colorado, Nebraska, Oklahoma - 340B Report

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] The post State Contract Pharmacy Lawsuit Roundup: Hearing in Utah; Updates in Colorado, Nebraska, Oklahoma appeared first on 340B Report.Salt Lake City · Salt Lake City Read Article

Trump Administration to Pilot 340B Rebate Model Next Year

100% Center coverage: 2 sources

The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs. Hospitals say 340B is a lifeline, while drugmakers say hospitals have abused the program.Pharma · United States See the Story

Who Are the Federal Judges Deciding the High-Stakes Drugmaker 340B Rebate Appeals? - 340B Report

Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...] The post Who Are the Federal Judges Deciding the High-Stakes Drugmaker 340B Rebate Appeals? appeared first on 340B Report.United States · United States Read Article

Drug Giants’ Rebate Plan Could Gut Rural Hospitals

100% Right coverage: 1 sources

A change to a federal drug discount policy that provides lower-cost prescription medications to clinics and hospitals serving low-income and other disadvantaged communities could bankrupt rural hospitals, a new study finds. The report, from 340B Health, claims that changes proposed by major drugmakers to replace upfront discounts with post-sale rebates for some or all outpatient drugs would hit safety-net hospitals with significant additional co…Layoffs · United States See the Story

News from 340breport.com